Innovation and R&D

R&D and Innovation

Home page

R&D and Innovation

R&D System and Platforms

Innovation Strategy

Innovation Pipeline

News Center

Innovation Drives Development, Focus Makes a "Little Giant": Viwit Recognized as a National Specialized, Refined, Distinctive, and Innovative "Little Giant" Enterprise in the Seventh Batch!

Viwit Pharmaceuticals Co., Ltd. Embarks on a New Journey: Fully Focused on Innovation, Driving the Future with Insight and Science

Viwit Pharmaceuticals Granted "Radiation Safety License": A Dual Milestone in Compliance and Innovation

Advancing into a New Chapter: Viwit Pharma Officially Launches Frontier Exploration in Targeted Gene and Cell Therapies

Viwit Pharmaceuticals' Sterile Production Facility Successfully Passes U.S. FDA Inspection

Viwit Pharmaceutical's Phenylephrine Hydrochloride Injection Officially Receives Official Approval by China NMPA

Achievements

Viwit also attaches great importance to the protection of innovation and has applied for more than 40 invention patents for the company's R&D projects.

VIWIT

Drug and Medical Device Internet Information Service Filing Number: 沪网药信备字〔2025〕00283号 Internet Information Service Filing Number: 沪ICP备12014533号

Technical Support:China Enterprise Cross-border | SEO Tags

【Business License】

Search